All Type of News
Leading drugmakers are in distress over legal action
Korea’s major pharmaceutical firms are under fire due to their lukewarm attitude on legal action against the government’s price cut plan.
The government plans to slash the price of about half the drugs on the marke...
Pharmacies at large retailer stores are perplexed by forcible closure on Sundays
The debate over limiting business hours at large discount stores is casting a cloud over revenue of some pharmacies operating in large discount stores.
Seoul City and other municipalities across the country have an...
Lawsuit against drug price cut getting fierce
A legal suit, ignited by Korean pharmaceutical firms, is getting fiercer as GUJU pharm and YOUNG POONG pharm unveiled their plans to defend their drug prices, which were reduced by the government’ anti-rebate rule, in...
Leading pharmaceutical firms criticized for passive legal action
The domestic leading pharmaceutical firms are under fire for their tepid attitude over legal action against the government’s plan to slash insured drug prices in April.
Dalim Biotech and KMS Pharma filed a legal su...
Passage of OTC drug sales bill is in doubt
A plan to allow the sale of over-the-counter drugs outside pharmacies is in doubt as there is no movement toward a relevant bill at the National Assembly.
In order for the bill to become law it must be approved by ...
Smaller pharmaceutical firms to hit hardest by government’s price cut plan
A chief executive of one of the smaller drug-making companies in Korea expressed concern about the country’s pharmaceutical industry.
“The recent legal action by two small drug makers reflects their urgency for sur...
Cash dividends at drug firms soar to 15%
Cash dividends paid out by KOSPI-listed pharmaceutical companies reached by average 15 percent in 2011 from a year before, Yakup.com said yesterday.
A total of 19 KOSPI-listed drug firms paid cash dividends, with t...
Health insurance spent 10.27 trillion won on drugs by classification of 50 therapeutic categories in
The national health insurance covered 10.27 trillion won in 2010, when insured medicines were classified by 50 therapeutic categories.
According to the Health, Insurance Review and Assessment Service (HIRA), an aff...
Drugmakers struggle for survival
Domestic pharmaceutical companies have thus far had an easy life thanks to the government’s misguided drug pricing formula introduced more than a decade ago, according to the Ministry of Health and Welfare.
The min...
Ilsung Pharma under fire over delayed law action
Ilsung Pharmaceutical Co. is under fire after it failed to take a lead in legal action against the government over the latter’s plan to slash drug prices in April.
Industry sources said small-sized Dalim Biotech an...
